Drug factory · FDA FEI 3008656542

MSN Laboratories Private Limited

Unit-II, Sy. No. 50, 53, 53/A, 54 & 54/A, Kardanur (Village), Patancheru (Mandal), , Sangareddy District, India

India: 1

Problems found, fixed voluntarily at FDA's last inspection, Mar 22, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2015: 2 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
DasatinibMakes the active ingredient Cycle Pharmaceuticals Ltd. 70709-151, 70709-152, 70709-153 +3

FDA inspection history

EndedResultProgramProblems noted
Mar 22, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
May 25, 2018No problems foundDrug Quality Assurance—
Apr 3, 2015No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.